Allan Saul

Allan Saul

Honorary Professor (Retired)

The Burnet Institute / University of Melbourne, Australia







Scientific Advisory Board Member


Research Keywords: 

Shigella, Salmonella, Streptococcus pyogenes, malaria, COVID-19, vaccine development, vaccine trials, epidemiology, disease modelling



I’ve worked on Infectious diseases since 1979.  Before retiring in January 2020 and returning to Australia, I was the Institute Director of the GSK Vaccines Institute for Global Health in Siena, Italy, since its inception in 2007 working on vaccines for Typhi, Paratyphi A, Shigella, invasive nontyphoidal Salmonella and Group A streptococcus.  Prior to this position, I was the co-branch chief of the Malaria Vaccine Development Branch I and help senior positions in the Queensland Institute of Medical Research in Brisbane, Australia with more than 25 years’ experience working on the development of experimental malaria vaccines, field work in epidemiology and testing control programs for malaria in endemic countries including malaria elimination programs in China and The Philippines and also led laboratory-based research in malaria antigen identification. 


My current interest is in finding practical ways to efficiently get therapeutics and diagnostics for major global health problems from initial proof of concept in humans, through Phase 3 and registration to sustainable production and implementation.


Related Websites: 

Profile page at The Burnet Institute


Key Publications: